Public Must Reset Expectations On Timing Of COVID-19 Vaccine Availability, Experts Say; China, Russia Seek To Market Vaccines Globally
STAT: It may be time to reset expectations on when we’ll get a Covid-19 vaccine
“The ambitious drive to produce Covid-19 vaccine at warp speed seems to be running up against reality. We all probably need to reset our expectations about how quickly we’re going to be able to be vaccinated. Pauses in clinical trials to investigate potential safety issues, a slower-than-expected rate of infections among participants in at least one of the trials, and signals that an expert panel advising the Food and Drug Administration may not be comfortable recommending use of vaccines on very limited safety and efficacy data appear to be adding up to a slippage in the estimates of when vaccine will be ready to be deployed…” (Branswell, 10/29).
AP: U.K. vaccine chief warns of over-optimism, early imperfection (Kirka, 10/28).
CNBC: WHO says Covid vaccine trials are ‘encouraging’ but it’ll take time to ensure it’s safe for everyone (Meredith, 10/28).
Fox News: First generation of coronavirus vaccines ‘likely to be imperfect,’ U.K. official warns (Hein, 10/28).
Kaiser Health News: Scientists warn Americans are expecting too much from a COVID-19 vaccine (Szabo/Aleccia, 10/28).
Los Angeles Times: Seeking to expand their influence, China and Russia market coronavirus vaccines around the world (Baumgaertner/McDonnell, 10/28).
Reuters: Activists urge ‘Big Pharma’ to be transparent on COVID-19 vaccine costs (Nebehay, 10/29).
Washington Post: As the world awaits a coronavirus vaccine, some in China get early doses (Dou, 10/29).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.